PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
16-Oct-2024 Honeywell and Salesforce Team Up to Deliver Life Sciences Solutions that Enable Safe and Streamlined Patient Care Honeywell
16-Oct-2024 90% of Hospital and Health System Revenue Cycle Leaders Believe GenAI Will Impact Medical Coding Operations AccessWire
16-Oct-2024 Biocomposites invests in InfectoTest GmbH – developers of a bacterial-specific point-of-care test for periprosthetic joint infection (PJI) Biocomposites
16-Oct-2024 ful. CashPay Welcomes BeneStream to Its Healthcare Ecosystem, Providing Medicaid, Medicare, CHIP, and ACA Assistance to Essential Workers AccessWire
16-Oct-2024 Envirotainer wins award for Most Diverse Range of Packaging at industry summit Envirotainer
16-Oct-2024 Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent Anti-Inflammatory Regulatory T Cells AccessWire
16-Oct-2024 Confidential Home Detox for Drugs and Alcohol Now Serving Los Angeles AccessWire
16-Oct-2024 Ikerian Announces Series B Funding First close of USD 8M (CHF 6.73M) Led by Sanoptis with Commercial Agreement to Expand RetinAI Discovery in Europe Ikerian AG
16-Oct-2024 Gepotidacin accepted for priority review by US FDA for treatment of uncomplicated urinary tract infections in female adults and adolescents GSK plc
16-Oct-2024 HUTCHMED announces that TAGRISSO® plus ORPATHYS® demonstrated high, clinically meaningful response rate in lung cancer patients with high levels of MET overexpression and/or amplification in SAVANNAH Phase II trial HUTCHMED
16-Oct-2024 53Biologics Awarded Best Company in Biotechnology Innovation at Farmaforum 53Biologics
16-Oct-2024 Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing Cytosurge AG
16-Oct-2024 ASTORIOM EXPANDS BIOREPOSITORY SERVICES WITH NEW ACQUISITION IN RESEARCH TRIANGLE PARK / ASTORIOM ACQUIRES BIOREPOSITORY BUSINESS IN RESEARCH TRIANGLE PARK AS IT EXPANDS ON THE EAST COAST ASTORIOM
16-Oct-2024 Molecure (WSE: MOC) and Nasdaq-listed biotechnology company Ocean Biomedical (NASDAQ: OCEA) sign an exclusive licensing agreement for the development and commercialization of selective YKL-40 inhibitors. Molecure S.A
16-Oct-2024 Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2024 Genmab
16-Oct-2024 Refeyn introduces new mass photometry products to streamline biomolecular analysis workflows Refeyn
16-Oct-2024 Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share Cycle Pharmaceuticals Ltd
16-Oct-2024 Jaguar Health Launches FDA-Approved Oral Mucositis Prescription Product Gelclair in the U.S. AccessWire
16-Oct-2024 £4.5 million project launched to tackle acute skills shortage in UK medicines manufacturing Innovate UK
16-Oct-2024 Labour budget can unlock UK life science opportunities ABPI